$1.96
-0.04-2.00%
In chiusura: Nov 20, 4:00 PM EST
$1.99
0.031.53%
After hour: 4:30 PM EST
Comments
Loading...
Report sulle vendite allo scoperto
Il short interest su Cardiff Oncology Inc (NASDAQ:CRDF) è diminuito durante l'ultimo periodo di rilevazione, aumentando da 14.26M a 14.25M. Questo rappresenta il 22% delle azioni disponibili pubblicamente dell'azienda.
Sulla base del volume medio recente di 759.48K azioni scambiate al giorno, ci vorrebbero 18.76 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
14.25M
Vendite allo scoperto %
22.0%
Giorni di copertura
18.76
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
CRDF | Cardiff Oncology, Inc. Common | 10/31/2025 | 11/11/2025 | 22.00% | 64,792,620 | 14,251,146 | 759,484 | 18.76 | |
CRDF | Cardiff Oncology, Inc. Common | 10/15/2025 | 10/24/2025 | 22.01% | 64,792,620 | 14,261,774 | 938,880 | 15.19 | |
CRDF | Cardiff Oncology, Inc. Common | 09/30/2025 | 10/09/2025 | 23.42% | 64,792,620 | 15,176,750 | 743,606 | 20.41 | |
CRDF | Cardiff Oncology, Inc. Common | 09/15/2025 | 09/24/2025 | 23.55% | 64,792,620 | 15,260,102 | 1,185,319 | 12.87 | |
CRDF | Cardiff Oncology, Inc. Common | 08/29/2025 | 09/10/2025 | 24.55% | 64,792,620 | 15,907,343 | 1,010,739 | 15.74 | |
CRDF | Cardiff Oncology, Inc. Common | 08/15/2025 | 08/26/2025 | 24.24% | 64,792,620 | 15,704,251 | 1,907,488 | 8.23 | |
CRDF | Cardiff Oncology, Inc. Common | 07/31/2025 | 08/11/2025 | 29.08% | 64,792,620 | 18,840,200 | 3,914,321 | 4.81 | |
CRDF | Cardiff Oncology, Inc. Common | 07/15/2025 | 07/24/2025 | 29.16% | 64,792,620 | 18,896,208 | 1,327,804 | 14.23 | |
CRDF | Cardiff Oncology, Inc. Common | 06/30/2025 | 07/10/2025 | 28.37% | 64,792,620 | 18,379,006 | 1,515,278 | 12.13 | |
CRDF | Cardiff Oncology, Inc. Common | 06/13/2025 | 06/25/2025 | 26.68% | 64,792,620 | 17,289,872 | 1,188,312 | 14.55 | |
CRDF | Cardiff Oncology, Inc. Common | 05/30/2025 | 06/10/2025 | 27.22% | 64,792,620 | 17,633,640 | 860,418 | 20.49 | |
CRDF | Cardiff Oncology, Inc. Common | 05/15/2025 | 05/27/2025 | 27.04% | 64,792,620 | 17,522,454 | 771,741 | 22.71 | |
CRDF | Cardiff Oncology, Inc. Common | 04/30/2025 | 05/09/2025 | 26.78% | 65,252,772 | 17,475,197 | 1,085,687 | 16.1 | |
CRDF | Cardiff Oncology, Inc. Common | 04/15/2025 | 04/25/2025 | 26.57% | 65,252,772 | 17,336,093 | 1,791,208 | 9.68 | |
CRDF | Cardiff Oncology, Inc. Common | 03/31/2025 | 04/09/2025 | 22.70% | 65,252,772 | 14,812,856 | 1,114,184 | 13.29 | |
CRDF | Cardiff Oncology, Inc. Common | 03/14/2025 | 03/25/2025 | 20.45% | 65,252,772 | 13,341,326 | 1,138,915 | 11.71 | |
CRDF | Cardiff Oncology, Inc. Common | 02/28/2025 | 03/11/2025 | 17.44% | 65,252,772 | 11,382,589 | 1,248,577 | 9.12 | |
CRDF | Cardiff Oncology, Inc. Common | 02/14/2025 | 02/26/2025 | 16.61% | 65,252,772 | 10,840,447 | 848,495 | 12.78 | |
CRDF | Cardiff Oncology, Inc. Common | 01/31/2025 | 02/11/2025 | 16.02% | 65,252,772 | 10,451,856 | 942,180 | 11.09 | |
CRDF | Cardiff Oncology, Inc. Common | 01/15/2025 | 01/27/2025 | 14.52% | 65,252,772 | 9,475,951 | 1,285,978 | 7.37 | |
CRDF | Cardiff Oncology, Inc. Common | 12/31/2024 | 01/10/2025 | 14.57% | 65,252,772 | 9,507,049 | 1,925,558 | 4.94 | |
CRDF | Cardiff Oncology, Inc. Common | 12/13/2024 | 12/24/2024 | 15.24% | 65,252,772 | 9,947,769 | 6,708,939 | 1.48 | |
CRDF | Cardiff Oncology, Inc. Common | 11/29/2024 | 12/10/2024 | 16.40% | 49,862,337 | 8,179,403 | 512,963 | 15.95 | |
CRDF | Cardiff Oncology, Inc. Common | 11/15/2024 | 11/26/2024 | 15.47% | 49,862,337 | 7,715,250 | 1,354,532 | 5.7 | |
CRDF | Cardiff Oncology, Inc. Common | 10/31/2024 | 11/11/2024 | 17.82% | 45,278,224 | 8,068,093 | 844,232 | 9.56 | |
CRDF | Cardiff Oncology, Inc. Common | 10/15/2024 | 10/24/2024 | 16.16% | 45,278,224 | 7,315,126 | 532,649 | 13.73 | |
CRDF | Cardiff Oncology, Inc. Common | 09/30/2024 | 10/09/2024 | 15.08% | 45,278,224 | 6,826,675 | 538,851 | 12.67 | |
CRDF | Cardiff Oncology, Inc. Common | 09/13/2024 | 09/24/2024 | 15.23% | 45,278,224 | 6,895,922 | 427,144 | 16.14 | |
CRDF | Cardiff Oncology, Inc. Common | 08/30/2024 | 09/11/2024 | 15.25% | 45,278,224 | 6,902,749 | 275,991 | 25.01 | |
CRDF | Cardiff Oncology, Inc. Common | 08/15/2024 | 08/26/2024 | 14.83% | 45,278,224 | 6,716,616 | 542,814 | 12.37 | |
CRDF | Cardiff Oncology, Inc. Common | 07/31/2024 | 08/09/2024 | 13.30% | 43,465,781 | 5,783,089 | 348,164 | 16.61 | |
CRDF | Cardiff Oncology, Inc. Common | 07/15/2024 | 07/24/2024 | 11.78% | 43,465,781 | 5,120,098 | 646,975 | 7.91 | |
CRDF | Cardiff Oncology, Inc. Common | 06/28/2024 | 07/10/2024 | 9.71% | 43,465,781 | 4,221,987 | 1,198,251 | 3.52 | |
CRDF | Cardiff Oncology, Inc. Common | 06/14/2024 | 06/26/2024 | 9.29% | 43,465,781 | 4,038,360 | 480,297 | 8.41 | |
CRDF | Cardiff Oncology, Inc. Common | 05/31/2024 | 06/11/2024 | 10.26% | 43,465,781 | 4,460,469 | 415,416 | 10.74 | |
CRDF | Cardiff Oncology, Inc. Common | 05/15/2024 | 05/24/2024 | 10.64% | 43,453,181 | 4,622,586 | 847,125 | 5.46 | |
CRDF | Cardiff Oncology, Inc. Common | 04/30/2024 | 05/09/2024 | 10.17% | 43,453,181 | 4,418,167 | 771,544 | 5.73 | |
CRDF | Cardiff Oncology, Inc. Common | 04/15/2024 | 04/24/2024 | 9.18% | 43,438,981 | 3,987,551 | 908,765 | 4.39 | |
CRDF | Cardiff Oncology, Inc. Common | 03/28/2024 | 04/09/2024 | 7.86% | 43,404,052 | 3,410,807 | 1,439,761 | 2.37 | |
CRDF | Cardiff Oncology, Inc. Common | 03/15/2024 | 03/26/2024 | 6.48% | 43,404,052 | 2,813,413 | 7,259,168 | 1 | |
CRDF | Cardiff Oncology, Inc. Common | 02/29/2024 | 03/11/2024 | 2.66% | 43,404,052 | 1,154,889 | 317,561 | 3.64 | |
CRDF | Cardiff Oncology, Inc. Common | 02/15/2024 | 02/27/2024 | 2.74% | 43,404,052 | 1,187,491 | 282,564 | 4.2 | |
CRDF | Cardiff Oncology, Inc. Common | 01/31/2024 | 02/09/2024 | 2.97% | 43,404,052 | 1,291,018 | 91,930 | 14.04 | |
CRDF | Cardiff Oncology, Inc. Common | 01/12/2024 | 01/24/2024 | 2.63% | 43,404,052 | 1,143,348 | 158,273 | 7.22 | |
CRDF | Cardiff Oncology, Inc. Common | 12/29/2023 | 01/10/2024 | 3.03% | 43,404,052 | 1,317,040 | 167,461 | 7.86 | |
CRDF | Cardiff Oncology, Inc. Common | 12/15/2023 | 12/27/2023 | 3.11% | 43,404,052 | 1,350,141 | 137,674 | 9.81 | |
CRDF | Cardiff Oncology, Inc. Common | 11/30/2023 | 12/11/2023 | 3.33% | 43,404,052 | 1,446,750 | 130,184 | 11.11 | |
CRDF | Cardiff Oncology, Inc. Common | 11/15/2023 | 11/27/2023 | 3.68% | 43,404,052 | 1,595,328 | 252,305 | 6.32 |
In cerca di azioni più vendute allo scoperto?